GH Research PLC
GH Research PLC (GHRS) Option Chain
Read more
Tracking the GHRS option chain helps you see every strike and expiry on GH Research PLC in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GHRS options activity at a glance. Use our scanner to monitor the GHRS option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GHRS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GHRS options are being actively traded, and where they are not.
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 10.65 | 0 | 0 | 0.47 | 5.03 | 3.50 | 7.50 | 12.50 | -28.69 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 89.35 |
| 30.37 | 0 | 0 | 0.92 | 2.53 | 1.50 | 5.40 | 15.00 | -14.43 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 69.63 |
| 54.18 | 0 | 0 | 2.47 | 0.03 | 0.20 | 4.80 | 17.50 | -0.17 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 45.82 |
| 73.93 | 1 | 0 | 4.90 | 0.00 | — | 4.90 | 20.00 | +14.09 | 0.50 | 4.90 | 2.47 | 0.23 | 0 | 0 | 26.07 |
| 86.73 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 22.50 | +28.35 | 3.00 | 7.00 | 4.97 | 0.03 | 0 | 0 | 13.27 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank34.52% Moderate
- Market cap (M$)1,204
- 52 weeks high-44.24%
- 52 weeks low45.60%
- Analyst recommendationStrong Buy
1.00 - Target price$43.00
145.29% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E—
- Future P/E—
- EPS (ttm)-0.94
- EPS growth next 5 years—
As of Nov 20, 2026